Please login to the form below
chronic pain
This page shows the latest chronic pain news and features for those working in and with pharma, biotech and healthcare.
Daily Brief: success for Pfizer and Lilly arthritis drug, Darzalex soars, IMI launches Accelerator
The 16-week study in patients with osteoarthritis (OA) pain evaluated subcutaneous administration of tanezumab, one of a new class of nerve growth factor (NGF) inhibitor drugs. ... In addition to OA pain, the biologic is being evaluated for chronic low
Latest news
-
Daily Brief: success for Pfizer and Lilly arthritis drug, Darzalex soars, IMI launches Accelerator
The 16-week study in patients with osteoarthritis (OA) pain evaluated subcutaneous administration of tanezumab, one of a new class of nerve growth factor (NGF) inhibitor drugs. ... In addition to OA pain, the biologic is being evaluated for chronic low
-
Europe's public-private alliance targets pain management
A key aim of the 23m scheme is to try to find alternatives to opioid analgesics for chronic pain – which have significant problems including side effects and the risk of addiction – ... and to identify ways to improve the care of people suffering
-
Iontas gets UK backing for chronic pain antibody project
Iontas gets UK backing for chronic pain antibody project. Receives just under £800, 000 from the UK government. ... neuropathy. Two other experimental drugs - Biogen’s BIIB074 and Xenon Pharma/Teva’s funapide - are also in phase II for chronic pain
-
Pfizer drops neuroscience R&D, cutting 300 jobs
chronic pain associated with osteoarthritis Lyrica (pregabalin) for fibromyalgia, as well as CNS-targeting drugs in its rare disease programme.
-
FDA approves Medtronic's tablet-controlled pain device
FDA approves Medtronic's tablet-controlled pain device. The Intellis system can be programmed via a Samsung's Galaxy S2. ... The Intellis system treats chronic pain via neurostimulation, the level of which can be adjusted wirelessly by the Samsung Galaxy
More from news
Approximately 2 fully matching, plus 89 partially matching documents found.
Latest Intelligence
-
Tools for the digital world
HealthUnlocked (HU) is one such network, designed to provide patients with a space in which they can discuss symptoms, relief and ways of coping with day-to-day chronic pain.
-
Pursuing better outcomes for people with pain
Pain is a sensation that we have all experienced in one form or another, but chronic pain that limits what people can do each day is unfortunately a reality for millions ... for chronic pain conditions.”.
-
Grünenthal's relentless pursuit of relief
The pursuit of pain relief is nowhere near over and many companies and institutions are chasing answers to reduce the impact of chronic pain and its corrosive byproducts: anxiety, fatigue, depression ... With one in five European adults affected by
-
Deal Watch January 2016
Focusing on development for chronic pain, Quartet will receive a $20m fee (representing the upfront and milestones) to cover development through to phase IIa. ... 150. MannKind/ Receptor Life Sciences. Licence, collaboration. Multiple inhaled therapeutic
-
Oral biologics delivery still elusive
At the moment, biologics are generally delivered by intravenous or subcutaneous injection, which is effective but not desirable for patients, particularly for chronic conditions. ... Cara Therapeutics has a chronic pain treatment based on a peptide that
More from intelligence
Approximately 0 fully matching, plus 11 partially matching documents found.
Latest appointments
-
Portland Health adds to staff as business grows
Meanwhile, Russell, who joins Portland Health after more than three years with Insight, is a parliamentary, public affairs and campaigns specialist, with experience in endocrinology, oncology, chronic pain, haematology and sexual
-
Bray Leino opens health and wellbeing PR practice
Diagnostics; and chronic pain for Pfizer.
-
Zogenix appoints Pfizer’s R Scott Shively as chief commercial officer
Pain specialist Zogenix has appointed former Pfizer VP R Scott Shively as its new chief commercial officer. ... for the treatment of chronic pain. “
More from appointments
Approximately 0 fully matching, plus 3 partially matching documents found.
Latest from PMHub
-
Research Partnership has published a new Living with Chronic Pain market report for 2016
Research Partnership has published a new Living with Chronic Pain market report for 2016. ... Chronic pain is defined as pain lasting longer than 6 months and affects 100 million Americans.
-
Research Partnership
Prescription medicines. Within prescription medicines, we have therapeutic specialists and experience in a broad range of therapy areas from chronic illnesses to rare diseases. ... 260 million people from mainland China now suffer from a chronic disease
More from PMHub
Approximately 1 fully matching, plus 1 partially matching documents found.
Featured jobs
-
Account Manager
-
£40, 000 - £45, 000 benefits
-
Senior Account Manager
-
Competitive salary commensurate with experience
- Home based, Chief Medical Writer, Medical Communications
-
Excellent package
- Business Unit Head, Medical Communications, London
-
Excellent package
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Home based, Editorial Team Leader, Medical Communications
-
Excellent package
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
- Account Director, Consumer Healthcare PR, Global PR agency
-
£50, 000 – £58, 000
-
Client Services Director - Med Comms
-
Great salary and bebefits
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Home based, Principal Medical Writer, Medical Communications
-
Excellent package
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
Subscribe to our email news alerts
- Moving annual total (MAT)
- Brexit rebels win vote on European Medicines Agency alignment
- Communiqué Awards 2018: Photo Gallery - Communiqué Awards 2016
- MaxCyte gets green light for solid tumour cell therapy
- NHS England to Vertex: come clean on Orkambi offer
- GSK sells eczema and psoriasis drug to Dermavant for £250m
- Random42 win Creativity International Award for Scientific Animation
- Merck & Co joins big pharma pricing pledge – but sceptics unconvinced
- Aurora partners with PIPHealth and taps into patient panels
- FDA’s Gottlieb lambasts industry’s biosimilar-blocking tactics
- Allergan’s abicipar matches AMD blockbuster Lucentis in phase III
- OUTiCO growth in multi-channel creates more job openings
PMHub
Cuttsy + Cuttsy
How do you understand what patients really need, without actually living their lives? How do you walk in someone else’s...
Latest intelligence
- Developing advocacy in the pharmaceutical industry.
- The importance of advocacy programmes...
- GDPR and events. What does the pharma industry need to know?
- Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
- Digital trends in B2B sales - how far behind is Pharma?
- The modern approach to B2B sales is data-driven, and enabled by digital tools....
Quick links
Infographics
